Inhibition of sphingosine-1-phosphate phosphatase 1 promotes cancer cells migration in gastric cancer: Clinical implications
暂无分享,去创建一个
J. Ji | L. Ye | X. Wen | Lin Li | Xiangyu Gao | K. Ji | Jun Cai | X. H. Wang | W. Jiang
[1] Danny Vesprini,et al. miRNA-95 mediates radioresistance in tumors by targeting the sphingolipid phosphatase SGPP1. , 2013, Cancer research.
[2] J. Ji,et al. Expression of signal-induced proliferation-associated gene 1 (SIPA1), a RapGTPase-activating protein, is increased in colorectal cancer and has diverse effects on functions of colorectal cancer cells. , 2012, Cancer genomics & proteomics.
[3] M. Shah,et al. Bevacizumab in combination with chemotherapy as first-line therapy in advanced gastric cancer: a biomarker evaluation from the AVAGAST randomized phase III trial. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[4] Joon-Oh Park,et al. Phase III trial comparing capecitabine plus cisplatin versus capecitabine plus cisplatin with concurrent capecitabine radiotherapy in completely resected gastric cancer with D2 lymph node dissection: the ARTIST trial. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[5] Y. Ohashi,et al. Five-year outcomes of a randomized phase III trial comparing adjuvant chemotherapy with S-1 versus surgery alone in stage II or III gastric cancer. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[6] S. Milstien,et al. Sphingosine-1-phosphate phosphohydrolase-1 regulates ER stress-induced autophagy , 2011, Cell Death and Differentiation.
[7] D. C. Simpson,et al. Sphingosine‐1‐phosphate produced by sphingosine kinase 2 in mitochondria interacts with prohibitin 2 to regulate complex IV assembly and respiration , 2011, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[8] P. Xia,et al. Sphingosine 1-phosphate, a key mediator of the cytokine network: juxtacrine signaling. , 2011, Cytokine & growth factor reviews.
[9] Yoon-Koo Kang,et al. Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial , 2010, The Lancet.
[10] Cheng Luo,et al. SPHINGOSINE-1-PHOSPHATE: A MISSING COFACTOR FOR THE E3 UBIQUITIN LIGASE TRAF2 , 2010, Nature.
[11] T. Huxford,et al. The crystal structure of sphingosine-1-phosphate in complex with a Fab fragment reveals metal bridging of an antibody and its antigen , 2009, Proceedings of the National Academy of Sciences.
[12] S. Milstien,et al. Regulation of Histone Acetylation in the Nucleus by Sphingosine-1-Phosphate , 2009, Science.
[13] Jacques Ferlay,et al. Recent patterns in gastric cancer: A global overview , 2009, International journal of cancer.
[14] W. Jiang,et al. Metastasis suppressor 1 (MTSS1) demonstrates prognostic value and anti-metastatic properties in breast cancer. , 2009, European journal of cancer.
[15] S. Spiegel,et al. Role of Sphingosine-1-Phosphate Phosphohydrolase 1 in the Regulation of Resistance Artery Tone , 2008, Circulation research.
[16] A. Cervantes,et al. The treatment of advanced gastric cancer: current strategies and future perspectives. , 2008, Annals of oncology : official journal of the European Society for Medical Oncology.
[17] H. Bonkovsky,et al. Vascular Endothelium As a Contributor of Plasma Sphingosine 1-Phosphate , 2008, Circulation research.
[18] Yusuf A. Hannun,et al. Principles of bioactive lipid signalling: lessons from sphingolipids , 2008, Nature Reviews Molecular Cell Biology.
[19] David Cunningham,et al. East meets west in the treatment of gastric cancer. , 2007, The New England journal of medicine.
[20] F. Rivera,et al. Chemotherapy of advanced gastric cancer. , 2007, Cancer treatment reviews.
[21] C. V. D. van de Velde,et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. , 2006, The New England journal of medicine.
[22] N. Petrelli. The debate is over; it's time to move on. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[23] J. Chun,et al. Lysophospholipid G Protein-coupled Receptors* , 2004, Journal of Biological Chemistry.
[24] Korey R. Johnson,et al. Role of Human Sphingosine-1-phosphate Phosphatase 1 in the Regulation of Intra- and Extracellular Sphingosine-1-phosphate Levels and Cell Viability* , 2003, Journal of Biological Chemistry.
[25] A. Falcone. Future strategies and adjuvant treatment of gastric cancer. , 2003, Annals of oncology : official journal of the European Society for Medical Oncology.
[26] A. Kihara,et al. Identification and Characterization of a Novel Human Sphingosine-1-phosphate Phosphohydrolase, hSPP2* , 2003, The Journal of Biological Chemistry.
[27] S. Payne,et al. Sphingosine‐1‐phosphate: dual messenger functions , 2002, FEBS letters.
[28] S. Milstien,et al. Sphingosine-1-phosphate phosphohydrolase in regulation of sphingolipid metabolism and apoptosis , 2002, The Journal of cell biology.
[29] T. Hla,et al. Lysophospholipids--Receptor Revelations , 2001, Science.
[30] Y. Hannun,et al. Cystic Fibrosis Transmembrane Regulator Regulates Uptake of Sphingoid Base Phosphates and Lysophosphatidic Acid , 2001, The Journal of Biological Chemistry.
[31] R. Mansel,et al. A hammerhead ribozyme suppresses expression of hepatocyte growth factor/scatter factor receptor c-MET and reduces migration and invasiveness of breast cancer cells. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.
[32] S. Mandala. Sphingosine-1-phosphate phosphatases. , 2001, Prostaglandins & other lipid mediators.
[33] S. Spiegel,et al. Molecular cloning and characterization of a lipid phosphohydrolase that degrades sphingosine-1- phosphate and induces cell death. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[34] K. Matsumoto,et al. Antagonistic effect of NK4, a novel hepatocyte growth factor variant, on in vitro angiogenesis of human vascular endothelial cells. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.
[35] Y. Hannun. Functions of Ceramide in Coordinating Cellular Responses to Stress , 1996, Science.
[36] W. Jiang,et al. Inhibition of hepatocyte growth factor-induced motility and in vitro invasion of human colon cancer cells by gamma-linolenic acid. , 1995, British Journal of Cancer.
[37] A. Jemal,et al. Global cancer statistics , 2011, CA: a cancer journal for clinicians.